LED Corporation owns 51.000.000 of Branch Pharmaceuticals bonds and classifies its investment as securities available for sale The market price of Branch's bonds feil by $450,000 due to concerns about one of the company's principal drugs. The concerns were justified when the FDA banned the drug $100.000 of that decline in value already had been included in Oci as a temporary corealized loss in a prior period. LED views $200,000 of the $450,000 loss as related to credit losses, and the other $250.000 as nocredit losses. LED does not plan to sell the investment and does not think it is more likely than not that it will have to sell the investment before fair value recovers. What journal entries should LED record to account for the decline in market value in the current period? How should the decineffect net income and comprehensive income? Complete this question by entering your answers in the tabs below. General Journal Effect What journal entries should LED record to account for the decline in market value in the current period? t no entry is required for a transaction/event, select "No journal entry required in the first account field.) View transaction list Journal entry worksheet Record the entry for reclassification adjustment Note: Friters before credits Event Gerveral oumal Dobit Credit Clear entry View general journal Record enly Effect>